RE:RE:RE:RE:RE:So what is next week PR?You are very welcome Starkicker.
I agree that the numbers are small in comparison, but keep in mind all of these medical CBD markets are in their infancy, and as these markets continue to grow yoy, so will Medipharms revenues in each region.
For example, in Germany they say only 2% of doctors prescribe CBD as a medical alternative largely due to confusion, lack of knowledge or education around CBD and its uses in the medical field.
Once that information becomes more mainstream, so will increased usage, relating to better numbers for those entrants like Medipharm with a foot already in the door.
The future looks very bright for these early stage suppliers, and I expect increased growth qoq across the international stage. That being said, tighter rules would help as well, as everyone and their dog appears to be trying to join the party, regulated or not